Clinical Trials
8
Active:0
Completed:5
Trial Phases
3 Phases
Phase 1:3
Phase 2:2
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (42.9%)Phase 2
2 (28.6%)Phase 4
2 (28.6%)The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2017-06-08
- Lead Sponsor
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Target Recruit Count
- 16
- Registration Number
- NCT03180333
- Locations
- 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China
The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Chronic Hepatitis B
- Interventions
- Drug: PNA 40mgDrug: PNA 240mgDrug: PNA 160mgDrug: PNA 80mgDrug: PNA PlaceboDrug: PNA 480mgDrug: PNA 360mg
- First Posted Date
- 2017-06-02
- Last Posted Date
- 2017-06-02
- Lead Sponsor
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Target Recruit Count
- 48
- Registration Number
- NCT03173599
- Locations
- 🇨🇳
Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China
The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis
Phase 4
- Conditions
- Bacterial Vaginosis
- Interventions
- First Posted Date
- 2017-03-15
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Target Recruit Count
- 300
- Registration Number
- NCT03080740
- Locations
- 🇨🇳
Peking University first hospital, Beijing, China
The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B
Phase 2
- Conditions
- Chronic Hepatitis B
- Interventions
- Drug: Metacavir Enteric-coated Capsules 80mgDrug: Metacavir Enteric-coated Capsules 320mgDrug: Metacavir Enteric-coated Capsules Placebo 320mgDrug: Metacavir Enteric-coated Capsules 160mgDrug: Metacavir Enteric-coated Capsules Placebo 160mgDrug: Metacavir Enteric-coated Capsules Placebo 240mg
- First Posted Date
- 2016-11-17
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Target Recruit Count
- 180
- Registration Number
- NCT02965859
- Locations
- 🇨🇳
81 Military Hospital of China, Nanjing, Jiangsu, China
The Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Cardiovascular Diseases
- Interventions
- First Posted Date
- 2016-09-07
- Last Posted Date
- 2016-09-13
- Lead Sponsor
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Target Recruit Count
- 44
- Registration Number
- NCT02889822
- Locations
- 🇨🇳
The Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
- Prev
- 1
- 2
- Next
News
No news found